Arboretum LifeSciences Raises $30M in Series A Funding

Arboretum LifeSciences, a Cambridge, MA-based molecular information company, has raised $30 million in a Series A financing round.

The round saw backers including F-Prime, GV, .406 Ventures, Hims & Hers, Amgen, and other healthcare investors.

The company will use the funding to build scientific and operational infrastructure, expand product development, increase the adoption of clinically indicated genetic testing and scale its longitudinal molecular research network.

What is Arboretum LifeSciences?

Arboretum LifeSciences is an AI-native molecular information company focused on making precision medicine more accessible for common diseases.

Read More:Biotech Startup KymaThera Raises $80M Series B Funding

The company combines AI and genetic testing to help healthcare systems identify patients at risk for preventable diseases and return actionable genomic findings to them.

Arboretum also works with biopharma companies by helping identify genomically profiled patients for clinical research and supporting more targeted clinical development.

For healthcare systems, the company provides clinical genetic testing and a collaborative research network. For therapeutics developers, it supports genomically stratified clinical development and new commercialization models.

How Much Funding Has Arboretum LifeSciences Raised?

Arboretum LifeSciences has raised $30 million in its Series A financing round.

The source does not provide details about previous funding rounds or the company’s total funding before this round.

Who Invested in Arboretum LifeSciences’ Series A Round?

The Series A round included:

• F-Prime
• GV
• .406 Ventures
• Hims & Hers
• Amgen
• Other healthcare investors

Why the Funding Matters

Arboretum plans to use the new funding to build scientific and operational infrastructure and expand its products.

The company will also use the capital to accelerate adoption of clinically indicated genetic testing and scale its longitudinal molecular research network.

Its work is aimed at integrating genetic testing into routine clinical care while generating molecular and clinical data that can support patient care, research and clinical trial enrollment.

Who founded Arboretum LifeSciences?

Arboretum LifeSciences was founded by Danielle Ciofani, Clare Bernard and Eric Banks.

The company is based in Cambridge, Massachusetts and was founded by leaders in data science from the Broad Institute.

“We started Arboretum to solve one of the biggest problems in therapeutics development: identifying genetically-defined populations that will have outsized benefit from common disease therapies,” said Anthony Philippakis, M.D., Ph.D., co-founder and CEO of Arboretum and general partner at GV.

“Drug developers in common diseases have historically had limited access to the large-scale genomic and clinical datasets critical to helping understand differences in disease biology and translate genetic insights into potential new treatment options,” said Michael Montalto, Ph.D., Vice President, Precision Medicine, Amgen.

Market and Business Growth

Arboretum has established initial partnerships with healthcare organizations including Advocate Health, Geisinger, Providence Healthcare and Cardiovascular Associates of America (CVA).

Through these partnerships, the company plans to help healthcare providers integrate genetic testing into routine care and build longitudinal molecular registries.

The company’s platform is also designed to support precision clinical trials, genomic medicine and the recruitment of genomically profiled patients for clinical research.

What Happens Next?

Arboretum will focus on expanding its scientific and operational infrastructure, developing its products and scaling its genetic testing and molecular research network.

The company will continue working with healthcare systems and biopharma companies to expand access to precision medicine and support clinical research and drug development.

Read More:Boston Dynamics Appoints Rohit Prasad as Chief Executive Officer